Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacologic cardiovascular support

G P Zaloga1, R C Prielipp, J F Butterworth

  • 1Department of Anesthesia/Critical Care, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina.

Critical Care Clinics
|April 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuromuscular monitoring and the cost of antagonism: when will we learn?

Anaesthesia·2017
Same author

Comparison of a prototype esophageal oximetry probe with two conventional digital pulse oximetry monitors in aortocoronary bypass patients.

Journal of clinical monitoring and computing·2003
Same author

Early enteral nutrition in acutely ill patients: a systematic review.

Critical care medicine·2002
Same author

Benzodiazepines in the intensive care unit.

Critical care clinics·2002
Same author

Less isoflurane is required after than before cardiopulmonary bypass to maintain a constant bispectral index value.

Journal of cardiothoracic and vascular anesthesia·2001
Same author

Reduced regional and global cerebral blood flow during fenoldopam-induced hypotension in volunteers.

Anesthesia and analgesia·2001
Same journal

Critical Care and Contagion: Evolving Frontiers of Infectious Diseases in the Modern Intensive Care Unit.

Critical care clinics·2026
Same journal

Advances and Challenges in Sepsis Care in Low-Resource Settings.

Critical care clinics·2026
Same journal

The Respiratory Triple Pandemic in the Intensive Care Unit: Epidemiology, Clinical Features and Management of COVID-19, Influenza and Respiratory Syncytial Virus.

Critical care clinics·2026
Same journal

Antibiotic Stewardship for the Intensivist.

Critical care clinics·2026
Same journal

Infection Prevention and Control in the Intensive Care Unit.

Critical care clinics·2026
Same journal

Antibiotic Considerations in the Critically Ill: Empiric Choices and Dosing.

Critical care clinics·2026
See all related articles

Newer inotropic agents improve outcomes in critically ill patients when used to optimize oxygen delivery. However, their elective use in heart failure patients may cause adverse events, necessitating further research into safer applications.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Pharmacology

Background:

  • Inotropic agents are increasingly used in critical care.
  • Elective use in chronic heart failure is linked to poor outcomes.
  • Optimizing tissue oxygen delivery with inotropes shows promise in critical illness.

Purpose of the Study:

  • To evaluate the role of inotropic agents in critically ill patients.
  • To differentiate outcomes based on the clinical setting of inotropic drug use.
  • To identify safer inotropic agents and their optimal applications.

Main Methods:

  • Review of current literature on inotropic agent application in critical care.
  • Analysis of outcomes associated with elective versus protocol-driven inotropic therapy.

Related Experiment Videos

  • Examination of adverse effects and benefits in different patient populations.

    • Main Results:

    • Inotropic drugs improve outcomes in critical illness when used to optimize oxygen delivery.
    • Elective use in cardiomyopathy and chronic heart failure is associated with adverse outcomes.
    • Specific clinical settings demonstrate improved outcomes with inotropic support.

    Conclusions:

    • Inotropic agents have a dichotomous effect on patient outcomes, dependent on clinical application.
    • Further research is needed to define optimal use in critical care and identify safer agents.
    • Careful patient selection and targeted protocols are crucial for effective inotropic therapy.